Dr. Steve S. Lee, MD

Dr. Lee practices at Surgery Center Mountain View in Mountain View, California.

Dr. Lee's NPI, 1972583490, was assigned on January 19, 2006. Dr. Lee graduated from Harvard Medical School in 1997. Dr. Lee holds California license A67457.

Dr. Lee's primary practice is Surgery Center Mountain View, at 701 E. El Camino Real, 1 Northwest, Mountain View, CA 94040. The practice phone is (408) 739-6000.

Dr. Lee's primary practice is Surgery Center Mountain View in Mountain View, California. Dr. Lee is also affiliated with El Camino Health - Mountain View Hospital. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Lee to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Lee is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Lee is licensed in California.

Dmand AI lists angioplasty, cardiac catheterization, endocarditis and pacemaker or defibrillator implantation among the conditions Dr. Lee treats.

CMS data shows 4,092 Medicare services from Dr. Lee across 30 procedure codes in 2024, for 1,784 Medicare patients. Medicare paid $299,765 for them.

CMS counts 1,784 Medicare patients who saw Dr. Lee in 2024. The largest group is 75 to 84, with 722 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 68, with 49% women.

In 2024, Dr. Lee wrote 5,421 Medicare Part D claims for 756 patients. 86% of them were for generic drugs. CMS names the drug for 5,267 of them, across 51 drugs with 11 or more claims each, at $1,116,430 in total drug cost. In 2023, CMS named 4,928 claims across 47 drugs.

Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lee as offering telehealth. CMS counts 34 procedures of coronary angioplasty and stenting by Dr. Lee, more than 71% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 46 papers to Dr. Lee, published from 2006 to 2025. 2023 was the busiest year, with 4. The most frequent topics are Attention Deficit Disorder with Hyperactivity, Tumor Microenvironment and Cell Line, Tumor. Dr. Lee has published most often in bioRxiv. Dr. Lee's most frequent co-authors are Raghava R. Gollapudi, MD, Bruce Bouland Baker, MD and John W. Christman, MD.

CMS Open Payments shows 21 general payments to Dr. Lee from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $250.

Dr. Lee graduated from Harvard Medical School in 1997.

Dr. Lee is in network with 12 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.